Learn More
Description
This gene encodes an enzyme that functions to both activate and deactivate arylamine and hydrazine drugs and carcinogens. Polymorphisms in this gene are responsible for the N-acetylation polymorphism in which human populations segregate into rapid, intermediate, and slow acetylator phenotypes. Polymorphisms in this gene are also associated with higher incidences of cancer and drug toxicity. A second arylamine N-acetyltransferase gene (NAT1) is located near this gene (NAT2). [provided by RefSeq
Specifications
Specifications
| Antigen | NAT2 |
| Applications | ELISA, Western Blot |
| Classification | Monoclonal |
| Clone | 3B5 |
| Conjugate | Unconjugated |
| Description | Mouse monoclonal antibody raised against a partial recombinant NAT2. |
| Formulation | PBS with no preservative; pH 7.4 |
| Gene | NAT2 |
| Gene Accession No. | BC015878 |
| Gene Alias | AAC2/PNAT |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.